Isthmus Partners’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,827
Closed -$601K 330
2017
Q3
$601K Sell
6,827
-4,567
-40% -$400K 0.17% 101
2017
Q2
$990K Sell
11,394
-122
-1% -$9.1K 0.29% 56
2017
Q1
$727K Buy
11,516
+145
+1% +$9.59K 0.21% 87
2016
Q4
$747K Buy
11,371
+66
+0.6% +$4.14K 0.23% 85
2016
Q3
$763K Buy
11,305
+131
+1% +$8.85K 0.24% 66
2016
Q2
$703K Sell
11,174
-237
-2% -$14.7K 0.23% 68
2016
Q1
$716K Sell
11,411
-953
-8% -$58.8K 0.24% 66
2015
Q4
$842K Buy
12,364
+399
+3% +$26K 0.29% 55
2015
Q3
$741K Sell
11,965
-193
-2% -$13K 0.27% 60
2015
Q2
$782K Sell
12,158
-40
-0.3% -$2.69K 0.26% 57
2015
Q1
$842K Buy
12,198
+120
+1% +$7.65K 0.29% 52
2014
Q4
$671K Buy
+12,078
New +$697K 0.23% 59

Other funds holding PRXL

Isthmus Partners's PRXL Position: Q4 2017 in Review

Isthmus Partners sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 6,827 shares — an estimated $601K sold.

Isthmus Partners first reported a position in PRXL in Q4 2014 and held it in 12 quarters. The position peaked at $990K in Q2 2017. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.

  • Isthmus Partners reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
  • Isthmus Partners sold 6,827 Parexel International Corp shares in Q4 2017, an estimated $601K.
  • Isthmus Partners first reported a position in Parexel International Corp in Q4 2014 and held it in 12 quarters.
  • Isthmus Partners's Parexel International Corp position peaked at $990K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.

Based on Isthmus Partners's 13F filing for Q4 2017, filed 5 Feb 2018.